Masaki Tajima

6PUBLICATIONS
51CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 13, 2026
Purine salvage pathway protects CD8+ T cells from metabolic stress.

Masaki Tajima, He Hao, Baihao Zhang

|Nov 02, 2024
Prostaglandin E2-EP2/EP4 signaling induces immunosuppression in human cancer by impairing bioenergetics and ribosome biogenesis in immune cells.

Siwakorn Punyawatthananukool, Ryuma Matsuura, Thamrong Wongchang

|May 15, 2023
Insights from a 30-year journey: function, regulation and therapeutic modulation of PD1.

Kenji Chamoto, Tomonori Yaguchi, Masaki Tajima

|Oct 27, 2022
Spermidine activates mitochondrial trifunctional protein and improves antitumor immunity in mice.

Muna Al-Habsi, Kenji Chamoto, Ken Matsumoto

|Jun 08, 2018
An increase in LRRK2 suppresses autophagy and enhances Dectin-1-induced immunity in a mouse model of colitis.

Tetsuya Takagawa, Atsushi Kitani, Ivan Fuss

Pageof 1